Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer.
about
Thymidine phosphorylase expression in normal and hyperplastic endometriumExpression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumorsThymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancerNovel targeted agents in the treatment of lung cancer.Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.Expression of the thymidine phosphorylase gene in epithelial ovarian cancer.Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha.A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.Expression of angiogenic growth factors in paragangliomas.Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.Thymidine phosphorylase activity in nonsmall cell lung carcinoma tissues.Thymidine phosphorylase: A potential new target for treating cardiovascular disease.Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages.Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma.Preoperative immunonutrition regulates tumor infiltrative lymphocytes and increases tumor angiogenesis in gastric cancer patients.A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.
P2860
Q24682942-65DC5FD2-D133-4844-A037-B08A81AB4CD2Q28143681-F7EEC9CE-60B2-4875-83DF-1A3E2AFFE402Q35588620-D133C574-128E-4238-B63F-F254A8F5BF34Q35790783-50268DCB-FF3B-437E-A111-E9AEBBF994D8Q36618182-A78A49C6-FAC5-4D08-932A-8894BB18D883Q36619392-174A3E01-2620-4DBC-B98E-E46BAEECD0E5Q36621744-BEF14751-7AC0-45D2-84F6-0FEBB778A58CQ37294590-9C6F64D6-D975-4CC1-B540-2844336DC1F0Q38283244-76CFA330-D3BE-4157-B1DE-87BB0EBF357FQ38466073-EB23B35A-96B6-4304-9082-0A8E9F4B5B6FQ42060633-008B8D0E-BCB4-4F5E-B03F-EDCCFA8C99A5Q43202368-9501173D-CB1E-43C6-BD7F-1759F1D6BF41Q43824298-B05B8982-9FB0-47D2-B22E-729636A1351DQ45305297-67793287-08FC-4AB5-9225-5EF7E5CFDAF4Q46416307-DBDF8335-B8A1-4472-800B-CADED67DF7BEQ46809718-9551D669-4415-4D6D-8F3B-A8BFF81A65ADQ47108890-4BE7E8C6-7DDB-4129-B735-2E4ABAB8E46BQ53230423-C8C3F53A-FF44-4B40-907A-82E7FD0DBF0E
P2860
Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Platelet-derived endothelial c ...... se) expression in lung cancer.
@en
type
label
Platelet-derived endothelial c ...... se) expression in lung cancer.
@en
prefLabel
Platelet-derived endothelial c ...... se) expression in lung cancer.
@en
P2093
P1476
Platelet-derived endothelial c ...... se) expression in lung cancer.
@en
P2093
Giatromanolaki A
Kaklamanis L
Koukourakis MI
P304
P356
10.1002/(SICI)1096-9896(199702)181:2<196::AID-PATH763>3.0.CO;2-U
P577
1997-02-01T00:00:00Z